LPL and hyperlipidemia: LPL in the liver has not been investigated under O-GlcNAc modified conditions but the O-GlcNAc potentiated transcription factor LXR (252), is a major driver of hepatic Lpl expression (253), including in response to dietary hyperlipidemia (254).